MAP1LC3A and hepatocellular carcinoma: Combined with EGCG, doxorubicin played a concentration-dependent inhibitory role in autophagy signaling through increased Beclin-1 and Atg5 expression to inhibit autophagy and suppressed LC3 expression in hepatoma Hep3B cells [194].